Summary
Guardant Health, Inc. (GH) held its 2019 annual meeting of stockholders on June 18, 2019, and this 8-K filing details the outcomes of the votes on the matters presented. Investors can note that both Class I director nominees, Aaref Hilaly and Stanley Meresman, were successfully elected to the Board of Directors. This indicates continued confidence in the current leadership and governance structure of the company. Furthermore, the company's appointment of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2019, was overwhelmingly ratified by the stockholders. This suggests a smooth operational and governance process, with no significant shareholder dissent on the key proposals put forth at the meeting. The strong approval margins for both proposals reinforce the established direction of the company.
Key Highlights
- 1Both Class I director nominees, Aaref Hilaly and Stanley Meresman, were elected to the Board of Directors.
- 2The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2019 was ratified.
- 3Proposal 1 (Director Elections) received significant 'FOR' votes, indicating strong shareholder support for the nominees.
- 4Proposal 2 (Ratification of Independent Auditor) was approved with a substantial majority of votes.
- 5The 2019 Annual Meeting of Stockholders was held on June 18, 2019.
- 6The filing confirms that only these two proposals were voted upon at the Annual Meeting.